Related Experiment Video

Updated: Jul 2, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer

Xiaodong Yu1, Zhongbo Du1, Pingyu Zhu1

  • 1Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China.

Pharmacological Reports : PR
|February 22, 2024
PubMed

Insights

Exosomal microRNAs (Exo-miRs) show promise as non-invasive biomarkers for diagnosing and monitoring renal cell carcinoma (RCC). These circulating molecules offer potential therapeutic targets for this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Renal cell carcinoma (RCC) is a lethal urological cancer lacking effective treatments and non-invasive diagnostic biomarkers.
  • Novel biomarkers and therapeutic targets are crucial for improving RCC patient outcomes.

Purpose of the Study:

  • To review the potential of circulating exosomal microRNAs (Exo-miRs) as diagnostic and prognostic biomarkers for RCC.
  • To explore the therapeutic potential of tumor microenvironment-derived Exo-miRs in RCC.

Main Methods:

  • Literature review of studies investigating Exo-miRs in renal cell carcinoma.
  • Analysis of Exo-miRs as potential non-invasive biomarkers and therapeutic targets.

Main Results:

  • Circulating Exo-miRs can be easily isolated and quantified, exhibiting high sensitivity and specificity.
  • Altered miR profiles in exosomes reflect the tumor's state, serving as a "fingerprint" for RCC.
  • Renal-specific miRs transported in exosomes are detectable, indicating biomarker potential.

Conclusions:

  • Exo-miRs represent a promising avenue for non-invasive diagnosis and prognosis of RCC.
  • Circulating Exo-miRs and tumor microenvironment-derived Exo-miRs offer potential therapeutic strategies for RCC.
Keywords:
DiagnosisExosomeMicroRNAPrognosisRenal cell carcinomaTherapy

More Related Videos

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile06:59

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

10.3K
A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model07:11

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model

Published on: September 11, 2020

1.4K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K